Press Release: ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

Dow Jones03-22
   Purchases of 
    marketable 
    securities              (471,604)         --         -- 
   Sales of marketable 
   securities                175,818          --         -- 
   Purchase of equipment 
    and facility 
    expansion                (34,197)     (1,846)    (5,192) 
                            --------    --------    ------- 
Net cash flows used in 
 investing activities       (329,983)     (1,738)    (5,191) 
 
Cash flows from 
financing activities 
   Payments on finance 
    leases                       (52)        (32)       (30) 
   Proceeds from 
   Business Combination, 
   including PIPE 
   financing, net of 
   associated costs of 
   $37,856                        --     542,503         -- 
   Borrowings under 
   related party notes 
   payable                        --      35,000         -- 
   Repurchase of Class A 
    ordinary shares           (9,499)         --         -- 
   Repayment of related 
    party notes payable           --     (35,000)        -- 
   Net cash contribution          --       6,050     71,500 
                            --------    --------    ------- 
Net cash flows (used in) 
 provided by financing 
 activities                   (9,551)    548,521     71,470 
 
Net change in cash and 
 cash equivalents           (429,603)    469,694     15,980 
Cash, beginning of period    490,252      20,558      4,578 
                            --------    --------    ------- 
Cash, end of period        $  60,649   $ 490,252   $ 20,558 
                            ========    ========    ======= 
 
Supplemental cash flow 
information: 
   Cash paid during the 
    period for income 
    taxes, net of 
    refunds                $   2,857   $   1,950   $     68 
                            ========    ========    ======= 
 
Supplemental disclosure 
of non-cash investing 
and financing 
activities: 
   Right of use assets 
    obtained in exchange 
    for lease 
    obligations            $   2,594   $   1,491   $     -- 
                            ========    ========    ======= 
   Exchange of Class B 
    ordinary shares        $   9,500   $      --   $     -- 
                            ========    ========    ======= 
   Impact of equity 
    transactions and 
    compensation on 
    redeemable 
    noncontrolling 
    interest               $   2,577   $   5,828   $     -- 
                            ========    ========    ======= 
   Change in redemption 
    value of 
    noncontrolling 
    interest               $      79   $      -- 
                            ========    ========   ======== 
   Equipment and facility 
    expansion included in 
    accounts payable and 
    accrued expenses       $     218   $      51   $  1,295 
                            ========    ========    ======= 
 

(END) Dow Jones Newswires

March 21, 2024 19:49 ET (23:49 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment